Skip to main content

Table 1 Baseline characteristics

From: Effects of a novel nutritional formula specially developed for chronic kidney disease patients on protein-restricted diets: a randomized controlled trial

Variable SUP CTR P value
n = 18 n = 22
Age (year) 65.9 ± 9.7 68.3 ± 8.7 0.43
Male to female 12:6 17:5 0.50
DM to non-DM 4:14 9:13 0.31
ARB/ACEI (use to non-use) 17:1 18:4 0.36
Body weight (kg) 65.6 ± 6.6 66.0 ± 8.9 0.86
BMI (kg/m2) 25.0 ± 1.8 24.6 ± 2.9 0.66
%IBW 114 ± 8 112 ± 13 0.66
Energy (kcal/kg IBW/day) 29 ± 4 28 ± 5 0.49
Protein (g/kg IBW/day) 0.75 ± 0.18 0.78 ± 0.19 0.67
BUN (mg/dL) 37.0 ± 12.3 49.7 ± 21.6 0.03
Creatinine (mg/dL) 3.9 ± 2.0 4.6 ± 3.4 0.44
eGFR (mL/min/1.73 m2) 15.4 ± 7.1 13.6 ± 6.8 0.43
Indoxyl sulfate (log μg/mL) (μg/mL) 0.71 ± 0.49 (5.2) 0.82 ± 0.29 (6.3) 0.36
Urine protein excretion (g/day) 0.9 ± 0.9 2.3 ± 3.9 0.15
CRP (mg/dL) 0.04 ± 0.04 0.11 ± 0.15 0.10
  1. Values inside parenthesis are the median
  2. SUP supplement group, CTR control group (no supplement), DM diabetes mellitus, ARB angiotensin II receptor blocker, ACEI angiotensin-converting enzyme inhibitor, BMI body mass index, IBW ideal body weight, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, CRP C-reactive protein